It was shown that 5-chloro-8-hydroxyquinoline, an antituberculosis agent, gels aqueous alcohol solutions efficiently. Thermal stability and gel-to-sol transition temperature of 1% gel in CD 3OD/D 2O (2:1) was studied by 1H-NMR. Fibrous structures of four xerogels have been characterized by scanning electron microscope.
References
[1]
Dye, C. Global epidemiology of tuberculosis. Lancet 2006, 367, 938–940, doi:10.1016/S0140-6736(06)68384-0.
[2]
Ahmad, Z.; Makaya, N.H.; Grosset, J. History of drug discovery: Early evaluation studies and lessons learnt from them. Prog. Respir. Res. 2011, 40, 2–9, doi:10.1159/000324894.
[3]
Hongmanee, P.; Rukseree, K.; Buabut, B.; Somsri, B.; Prasit, P. In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2007, 51, 1105–1106, doi:10.1128/AAC.01310-06.
[4]
Darby, C.M.; Nathan, C.F. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxy-quinoline. J. Antimicrob. Chemother. 2010, 65, 1424–1427, doi:10.1093/jac/dkq145.
[5]
Enquist, P.-A.; Gylfe, ？.; H？gglund, U.; Lindstr？m, P.; Norberg-Scherman, H.; Sundin, C.; Elofsson, M. Derivatives of 8-hydroxyquinoline-Antibacterial agents that target intra- and extracellular Gram-negative pathogens. Bioorg. Med. Chem. Lett. 2012, 22, 3550–3553, doi:10.1016/j.bmcl.2012.03.096.
[6]
Ma, Z.; Moulton, B. A novel polymorph of 5-chloro-8-hydroxyquinoline with improved water solubility and faster dissolution rate. J. Chem. Crystallogr. 2009, 39, 913–918, doi:10.1007/s10870-009-9591-3.
[7]
Fernández-Bachiller, M.I.; Pérez, C.; González-Munoz, G.C.; Conde, S.; López, M.G.; Villarroya, M.; García, A.G.; Rodríguez-Franco, M.I. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. J. Med. Chem. 2010, 53, 4927–4937.
[8]
Kharadia, G.J.; Patel, J.R.; Dholakiy, B.Z. Antituberculosis, antifungal and thermal activity of mixed ligand transition metal complexes. Appl. Organomet. Chem. 2010, 24, 821–827, doi:10.1002/aoc.1711.
[9]
Ma, Z.; Moulton, B. Mixed-Ligand Coordination Species: A Promising Approach for “Second-Generation” Drug Development. Cryst. Growth Des. 2007, 7, 196–198, doi:10.1021/cg060602f.
Pasipanodya, J.G.; Gumbo, T. A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs. Curr. Opin. Pharmacol. 2011, 11, 457–463, doi:10.1016/j.coph.2011.07.001.
[12]
Sangeetha, N.M.; Maitra, U. Supramolecular gels: Functions and uses. Chem. Soc. Rev. 2005, 34, 821–836, doi:10.1039/b417081b.
[13]
Svobodová, H.; Noponen, V.; Kolehmainen, E.; Siev？nen, E. Recent advances in steroidal supramolecular gels. RSC Adv. 2012, 2, 7840–7847.
[14]
Latosińska, J.N.; Latosińska, M.; Tomczak, M.A.; Seliger, J.; ？agar, V. Supramolecular synthon pattern in solid clioquinol and cloxiquine (APIs of antibacterial, antifungal, antiaging and antituberculosis drugs) studied by 35Cl NQR, 1H-17O and 1H-14N NQDR and DFT/QTAIM. J. Mol. Model. 2011, 17, 1781–1800, doi:10.1007/s00894-010-0876-4.
[15]
Svobodová, H.; Nonappa; Lahtinen, M.; Wimmer, Z.; Kolehmainen, E. A steroid-based gelator of A(LS)2 type: Tuning gel properties by metal coordination. Soft Matter 2012, 8, 3840–3847.
[16]
Iqbal, S.; Rodríguez-LLansola, F.; Escuder, B.; Miravet, J.F.; Verbruggen, I.; Willemis, R. HRMAS 1H-NMR as a tool for the study of supramolecular gels. Soft Matter 2010, 6, 1875–1878, doi:10.1039/b926785a.
[17]
Spectral Database for Organic Compounds. Available online: http://riodb01.ibase.aist.go.jp/sdbs/cgi-bin/cre_index.cgi?lang=eng (accessed on 18 September 2012).
